CHPA Eyes DXM Action, FDA Revitalization, Imports As Congress Returns
This article was originally published in The Tan Sheet
Executive Summary
In an Aug. 29 interview with "The Tan Sheet," Consumer Healthcare Products Association General Counsel Andy Fish, also the group's senior vice president of legal and government affairs, discussed CHPA's outlook during the rest of the congressional session for legislative activity that could affect the over-the-counter drug industry